Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial
Tóm tắt
Từ khóa
Tài liệu tham khảo
Moayyedi, 2004, Helicobacter pylori public health implications, Helicobacter, 9, 67, 10.1111/j.1083-4389.2004.00250.x
Malfertheiner, 2007, Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report, Gut, 56, 772, 10.1136/gut.2006.101634
Asaka, 2010, Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition, Helicobacter, 15, 1, 10.1111/j.1523-5378.2009.00738.x
Chey, 2007, American College of Gastroenterology guideline on the management of Helicobacter pylori infection, Am J Gastroenterol, 102, 1808, 10.1111/j.1572-0241.2007.01393.x
Fock, 2009, Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection, J Gastroenterol Hepatol, 24, 1587, 10.1111/j.1440-1746.2009.05982.x
Fukase, 2008, Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial, Lancet, 372, 392, 10.1016/S0140-6736(08)61159-9
Graham, 2005, Novel bismuth-metronidazole-tetracycline triple-layer tablet for treatment of Helicobacter pylori, Aliment Pharmacol Ther, 21, 165, 10.1111/j.1365-2036.2005.02322.x
O'Morain, 2003, Efficacy and safety of single triple capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole for eradication of Helicobacter pylori: an international multicenter study, Aliment Pharmacol Ther, 17, 415, 10.1046/j.1365-2036.2003.01434.x
De Francesco, 2010, Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits, J Antimicrob Chemother, 65, 327, 10.1093/jac/dkp445
Graham, 2010, Helicobacter pylori treatment in the era of increasing antibiotic resistance, Gut, 59, 1143, 10.1136/gut.2009.192757
Mégraud, 2004, H pylori antibiotic resistance: prevalence, importance, and advances in testing, Gut, 53, 1374, 10.1136/gut.2003.022111
Hillemand, 1977, Bismuth treatment and blood bismuth levels, Sem Hop, 53, 1663
De Francesco, 2007, Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy, J Antimicrob Chemother, 59, 783, 10.1093/jac/dkm005
Blaser, 2002, The genetic gymnastics of our indigenous microbes, N Engl J Med, 346, 2083, 10.1056/NEJMcibr020229
Koletzko, 2006, Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe, Gut, 55, 1711, 10.1136/gut.2006.091272
Boyanova, 2009, Prevalence of multidrug-resistant Helicobacter pylori in Bulgaria, J Med Microbiol, 58, 930, 10.1099/jmm.0.009993-0
Mégraud, 2007, Helicobacter pylori detection and antimicrobial susceptibility testing, Clin Microbiol Rev, 20, 280, 10.1128/CMR.00033-06
Graham, 2000, Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study, Aliment Pharmacol Ther, 14, 745, 10.1046/j.1365-2036.2000.00770.x
Goodwin, 1988, Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies, J Clin Pathol, 41, 207, 10.1136/jcp.41.2.207
Tsugawa, 2011, Two amino acids mutation of ferric uptake regulator determines Helicobacter pylori resistance to metronidazole, Antioxid Redox Signal, 14, 15, 10.1089/ars.2010.3146
Ford, 2008, Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis, World J Gastroenterol, 14, 7361, 10.3748/wjg.14.7361
Chiba, 2000, Effects of in vitro antibiotic resistance on treatment: bismuth-containing regimens, Can J Gastroenterol, 14, 885, 10.1155/2000/709640
Luther, 2010, Empiric quadruple vs triple therapy for primary treatment of Helicobacter pylori infection: systematic review and meta-analysis of efficacy and tolerability, Am J Gastroenterol, 105, 65, 10.1038/ajg.2009.508
Buge, 1974, 20 cases of acute encephalopathy with myoclonia during treatment with oral bismuth salts, Ann Med Intern, 124, 877
Slikkerveer, 1989, Pharmacokinetics and toxicity of bismuth compounds, Med Toxicol Adverse Drug Exp, 4, 303, 10.1007/BF03259915
Mégraud, 2005, Update on therapeutic options for Helicobacter pylori-related diseases, Curr Infect Dis Rep, 7, 115, 10.1007/s11908-005-0071-4
Fuccio, 2007, Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication, Ann Intern Med, 147, 553, 10.7326/0003-4819-147-8-200710160-00008
Saad, 2006, Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis, Am J Gastroenterol, 101, 488, 10.1111/j.1572-0241.2006.00637.x
Jadad, 1996, Assessing the quality of reports of randomized clinical trials: is blinding necessary?, Control Clin Trials, 17, 1, 10.1016/0197-2456(95)00134-4
Zagari, 2007, Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER study, Gut, 56, 475, 10.1136/gut.2006.102269
Glupczynski, 2002, Comparison of the E test and agar dilution method for antimicrobial susceptibility testing of Helicobacter pylori, Eur J Clin Microbiol Infect Dis, 21, 549, 10.1007/s10096-002-0757-6
Fischbach, 2007, Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori, Aliment Pharmacol Ther, 26, 343, 10.1111/j.1365-2036.2007.03386.x
Essa, 2009, Meta-analysis: four-drug, three antibiotic, non-bismuth-containing “concomitant therapy” versus triple therapy for Helicobacter pylori eradication, Helicobacter, 14, 109, 10.1111/j.1523-5378.2009.00671.x
Graham, 2008, New concepts of resistance in the treatment of Helicobacter pylori infections, Nat Clin Pract Gastroenterol Hepatol, 5, 321, 10.1038/ncpgasthep1138